3009 Insertion subdomain in DsbA-like
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Homogeneous metal compounds | 6 | 7.3 | 0.83× | q = 0.69 | |
| Organosulfur compounds | 2 | 0.3 | 6.57× | not tested | |
| Phenylpropanoids and polyketides | 2 | 0.3 | 6.50× | not tested | |
| Organic nitrogen compounds | 2 | 0.5 | 4.24× | not tested | |
| Benzenoids | 3 | 1.1 | 2.77× | not tested | |
| Organic acids and derivatives | 6 | 2.3 | 2.62× | not tested | |
| Organic oxygen compounds | 3 | 3.0 | 1.02× | not tested | |
| Organoheterocyclic compounds | 2 | 2.3 | 0.88× | not tested | |
| Homogeneous non-metal compounds | 2 | 3.2 | 0.63× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00143 | GSH | Glutathione | 11 |
| DB02580 | PG6 | Pentaglyme | 4 |
| DB02219 | CXS | 3-(cyclohexylamino)propanesulfonic acid | 3 |
| DB03904 | URE | Urea | 2 |
| DB04700 | GSF | GLUTATHIONE SULFINATE | 2 |
| DB06770 | 010 | Benzyl alcohol | 2 |
| DB06952 | 2C2 | (2S)-2-HYDROXY-2H-CHROMENE-2-CARBOXYLIC ACID | 2 |
| DB08636 | TOH | 2-Hydroxybenzalpyruvate | 2 |
| DB08637 | TOM | 4-(2-METHOXYPHENYL)-2-OXOBUT-3-ENOIC ACID | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MGmetal | MAGNESIUM ION | 7 |
| GTX | S-HEXYLGLUTATHIONE | 6 |
| GSH | Glutathione | 5 |
| PG6 | 1-(2-METHOXY-ETHOXY)-2-{2-[2-(2-METHOXY-ETHOXY]-ETHOXY}-ETHANE | 4 |
| SW0 | N-(2-fluorophenyl)-5-methyl-1,2-oxazole-3-carboxamide | 4 |
| CXS | 3-CYCLOHEXYL-1-PROPYLSULFONIC ACID | 3 |
| 010 | phenylmethanol | 2 |
| 1YO | 3-[(2-methylbenzyl)sulfanyl]-4H-1,2,4-triazol-4-amine | 2 |
| 2C2 | (2S)-2-HYDROXY-2H-CHROMENE-2-CARBOXYLIC ACID | 2 |
| 5V9 | ~{N}-[(4-thiophen-3-ylphenyl)methyl]cyclohexanamine | 2 |
| A1BX8 | N-(2-aminophenyl)-5-methyl-1,2-oxazole-3-carboxamide | 2 |
| A1BYA | N-(2-amino-3-fluorophenyl)-5-methyl-1,2-oxazole-3-carboxamide | 2 |
| A1CJJ | N-[3-(3-{[(2R)-2-hydroxybutyl]amino}-3-oxoprop-1-yn-1-yl)phenyl]-5-methyl-1,2-oxazole-3-carboxamide | 2 |
| A1CJK | N-[3-(3-{[(1S)-2-hydroxy-1-phenylethyl]amino}-3-oxoprop-1-yn-1-yl)phenyl]-5-methyl-1,2-oxazole-3-carboxamide | 2 |
| A1CQW | N-[3-(3-{[(2S)-2-hydroxybutyl]amino}-3-oxoprop-1-yn-1-yl)phenyl]-5-methyl-1,2-oxazole-3-carboxamide | 2 |
| CAmetal | CALCIUM ION | 2 |
| CDmetal | CADMIUM ION | 2 |
| CL | CHLORIDE ION | 2 |
| GSF | L-GAMMA-GLUTAMYL-3-SULFINO-L-ALANYLGLYCINE | 2 |
| Q2O | 1-methyl-1H-pyrazol-5-amine | 2 |